Alternatively, by injecting MPEI/pCAR-IFN-γ intraperitoneally in tumor-bearing mice authors showed presence of CAR+ immune cells in liver, kidney and tumor mass as well as a significant effect on tumor control, even considering it less pronounced than intratumoral infusion. The gene discussed is IFNG; the disease is neoplasm.